This genetic sequencing panel looks at single nucleotide variations (SNVs) in a small number of genes linked to cognitive ability, metabolic problems, and specific health responses. This panel focuses on genetic predispositions for diseases that influence cognition, metabolism, hearing, speech, and drug responsiveness. Its findings can inform personalised therapies such as food and lifestyle changes, early medical intervention, and individualized drug dose.
- Math’s ability
- Alport syndrome
- PAH deficiency
- MCADD
- GJB2 Associated hearing loss
- Stuttering